Mylan Launches Generic Angiomax® Injection

Mylan Launches Generic Angiomax® Injection

June 18, 2018 – Bivalirudin for Injection is an anticoagulant intended for use with aspirin – HERTFORDSHIRE, England and PITTSBURGH, June 18, 2018 /PRNewswire/ — Global pharmaceutical company Mylan N.V.(NASDAQ: MYL) today announced the U.S. launch of Bivalirudin for Injection, 250 mg single-dose vial, a generic